SCHEMBL12366342

SCHEMBL12366342

[C-]#[N+]c1c(C(F)(F)F)cc(-c2cccc(C)c2)n(Cc2ccc(Cl)cc2)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 4/20 0.39
HPGD P15428 2/20 0.39
TRPC5 Q9UL62 3/20 0.39
ORAI1 Q96D31 1/20 0.38
MDM2 Q00987 4/20 0.37
CNR2 P34972 1/20 0.37
PTGES2 Q9H7Z7 1/20 0.37
ALDH1A1 P00352 4/20 0.36
P2RX3 P56373 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
PPARG P37231 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366250 0.94 MAPT (0.40) TP53MAPTMDM2P2RX3ITGB1
SCHEMBL12366330 0.92 RGS4 (0.41) TP53POLBMAPTKDM4EHPGD
SCHEMBL12366295 0.92 ITGB1 (0.39) TP53MAPTHPGDMDM2ALDH1A1
SCHEMBL12366493 0.92 MDM2 (0.36) MAPTMDM2ITGB1ITGA4ITGB7
SCHEMBL12366288 0.92 MDM2 (0.41) MDM2
SCHEMBL12366233 0.92 CNR1 (0.42) TP53MAPTKDM4EHPGDMDM2
SCHEMBL12366495 0.91 MDM2 (0.38) MDM2ITGB1ITGA4ITGB7
SCHEMBL12366415 0.91 CCR2 (0.41) TP53POLBMAPTMDM2ALDH1A1
SCHEMBL12366746 0.91 PTGS2 (0.36) MAPTTRPC5MDM2ITGB1ITGA4
SCHEMBL12366335 0.91 LMNA (0.35) TP53MAPTMDM2ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed